Page 7 - Societal Cdmo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

  $Interest expense 15.0   15.2 Depreciation 7.5   6.5 Amortization of intangible assets 0.9   1.0 Stock-based... | August 10, 2022

EXTON, Pa. (AP) _ Societal CDMO, Inc. (SCTL) on Wednesday reported a loss of $4.3 million...

Societal CDMO (NASDAQ:SCTL – Get Rating) is one of 938 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it weigh in compared to its peers? We will compare Societal CDMO to related businesses based on the strength of its valuation, profitability, dividends, institutional ownership, analyst recommendations, risk and earnings. Volatility and Risk Societal […]

Societal CDMO (NASDAQ:SCTL – Get Rating) is one of 937 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it weigh in compared to its competitors? We will compare Societal CDMO to related companies based on the strength of its risk, institutional ownership, dividends, valuation, profitability, analyst recommendations and earnings. Profitability This table compares […]

Zacks Investment Research upgraded shares of Societal CDMO (NASDAQ:SCTL – Get Rating) from a hold rating to a buy rating in a report published on Thursday morning, Zacks.com reports. Zacks Investment Research currently has $2.00 price target on the stock. According to Zacks, “Recro Pharma, Inc. is a clinical stage specialty pharmaceutical company. It develops […]